KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Assets: 2009-2024

Historic Assets for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $3.3 billion.

  • Idexx Laboratories' Assets rose 1.07% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year increase of 1.07%. This contributed to the annual value of $3.3 billion for FY2024, which is 1.03% up from last year.
  • Per Idexx Laboratories' latest filing, its Assets stood at $3.3 billion for FY2024, which was up 1.03% from $3.3 billion recorded in FY2023.
  • Over the past 5 years, Idexx Laboratories' Assets peaked at $3.3 billion during FY2024, and registered a low of $2.3 billion during FY2020.
  • Its 3-year average for Assets is $3.1 billion, with a median of $3.3 billion in 2023.
  • Data for Idexx Laboratories' Assets shows a peak YoY increased of 25.22% (in 2020) over the last 5 years.
  • Idexx Laboratories' Assets (Yearly) stood at $2.3 billion in 2020, then rose by 6.22% to $2.4 billion in 2021, then increased by 12.70% to $2.7 billion in 2022, then rose by 18.68% to $3.3 billion in 2023, then grew by 1.03% to $3.3 billion in 2024.